| Year |
Citation |
Score |
| 2016 |
Vojtechova Z, Sabol I, Salakova M, Smahelova J, Zavadil J, Turek L, Grega M, Klozar J, Prochazka B, Tachezy R. Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones. Bmc Cancer. 16: 382. PMID 27377959 DOI: 10.1186/S12885-016-2430-Y |
0.731 |
|
| 2015 |
Vojtechova Z, Sabol I, Salakova M, Turek L, Grega M, Smahelova J, Vencalek O, Lukesova E, Klozar J, Tachezy R. Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis. International Journal of Cancer. Journal International Du Cancer. PMID 26239888 DOI: 10.1002/Ijc.29712 |
0.74 |
|
| 2015 |
Lace MJ, Anson JR, Haugen TH, Dierdorff JM, Turek LP. Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration. Carcinogenesis. 36: 151-9. PMID 25416558 DOI: 10.1093/carcin/bgu236 |
0.693 |
|
| 2014 |
Lace MJ, Turek LP, Anson JR, Haugen TH. Analyzing the Human Papillomavirus (HPV) Life Cycle in Primary Keratinocytes with a Quantitative Colony-Forming Assay. Current Protocols in Microbiology. 33: 14B.2.1-14B.2.13. PMID 24789595 DOI: 10.1002/9780471729259.mc14b02s33 |
0.667 |
|
| 2012 |
Smith EM, Rubenstein LM, Haugen TH, Pawlita M, Turek LP. Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. Journal of Oncology. 2012: 571862. PMID 22315596 DOI: 10.1155/2012/571862 |
0.725 |
|
| 2011 |
Rubenstein LM, Smith EM, Pawlita M, Haugen TH, Hamšíková E, Turek LP. Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infectious Agents and Cancer. 6: 9. PMID 21740566 DOI: 10.1186/1750-9378-6-9 |
0.702 |
|
| 2011 |
Lace MJ, Anson JR, Klussmann JP, Wang DH, Smith EM, Haugen TH, Turek LP. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers. Journal of Virology. 85: 1645-54. PMID 21123375 DOI: 10.1128/JVI.02093-10 |
0.701 |
|
| 2010 |
Smith EM, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP. Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers. Cancer Causes & Control : Ccc. 21: 1369-78. PMID 20401530 DOI: 10.1007/S10552-010-9564-Z |
0.783 |
|
| 2010 |
Smith EM, Parker MA, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP. Evidence for vertical transmission of HPV from mothers to infants. Infectious Diseases in Obstetrics and Gynecology. 2010: 326369. PMID 20300545 DOI: 10.1155/2010/326369 |
0.717 |
|
| 2010 |
Smith EM, Rubenstein LM, Hoffman H, Haugen TH, Turek LP. Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infectious Agents and Cancer. 5: 4. PMID 20181227 DOI: 10.1186/1750-9378-5-4 |
0.608 |
|
| 2010 |
Lace MJ, Anson JR, Haugen TH, Turek LP. Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes. Virology. 399: 270-9. PMID 20129639 DOI: 10.1016/J.Virol.2009.12.025 |
0.7 |
|
| 2010 |
Smith EM, Pawlita M, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. International Journal of Cancer. Journal International Du Cancer. 127: 111-7. PMID 19876924 DOI: 10.1002/Ijc.25015 |
0.642 |
|
| 2009 |
Lace MJ, Anson JR, Klingelhutz AJ, Lee JH, Bossler AD, Haugen TH, Turek LP. Human papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs. Journal of Virology. 83: 11784-94. PMID 19740985 DOI: 10.1128/Jvi.01370-09 |
0.845 |
|
| 2009 |
Lace MJ, Anson JR, Klingelhutz AJ, Harada H, Taniguchi T, Bossler AD, Haugen TH, Turek LP. Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. Carcinogenesis. 30: 1336-44. PMID 19541854 DOI: 10.1093/Carcin/Bgp150 |
0.823 |
|
| 2009 |
Lace MJ, Isacson C, Anson JR, Lörincz AT, Wilczynski SP, Haugen TH, Turek LP. Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture. Journal of Virology. 83: 7457-66. PMID 19458011 DOI: 10.1128/JVI.00285-09 |
0.708 |
|
| 2009 |
Haugen TH, Lace MJ, Ishiji T, Sameshima A, Anson JR, Turek LP. Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation. Virology. 389: 82-90. PMID 19410271 DOI: 10.1016/j.virol.2009.04.002 |
0.319 |
|
| 2009 |
Nowicki P, Hoover A, De Geest K, Goodheart M, Lace M, Haugen T, Turek L, Strand G, Bossler A, Klingelhutz A, Lee J. Protein tyrosine phosphatase nonreceptor 13 (PTPN13) is targeted by human papillomavirus 16 E6 in cervical epithelium Infectious Agents and Cancer. 4. DOI: 10.1186/1750-9378-4-S2-P31 |
0.738 |
|
| 2008 |
Lace MJ, Anson JR, Turek LP, Haugen TH. Functional mapping of the human papillomavirus type 16 E1 cistron. Journal of Virology. 82: 10724-34. PMID 18753208 DOI: 10.1128/JVI.00921-08 |
0.66 |
|
| 2008 |
Lace MJ, Anson JR, Thomas GS, Turek LP, Haugen TH. The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. Journal of Virology. 82: 10841-53. PMID 18753207 DOI: 10.1128/JVI.01481-08 |
0.559 |
|
| 2008 |
Smith EM, Rubenstein LM, Ritchie JM, Lee JH, Haugen TH, Hamsikova E, Turek LP. Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers? Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2087-96. PMID 18708401 DOI: 10.1158/1055-9965.Epi-08-0054 |
0.771 |
|
| 2008 |
Smith EM, Wang D, Rubenstein LM, Morris WA, Turek LP, Haugen TH. Association between p53 and human papillomavirus in head and neck cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 421-7. PMID 18268127 DOI: 10.1158/1055-9965.Epi-07-2597 |
0.736 |
|
| 2008 |
Smith EM, Wang D, Kim Y, Rubenstein LM, Lee JH, Haugen TH, Turek LP. P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncology. 44: 133-42. PMID 17360226 DOI: 10.1016/J.Oraloncology.2007.01.010 |
0.738 |
|
| 2007 |
Smith EM, Swarnavel S, Ritchie JM, Wang D, Haugen TH, Turek LP. Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. The Pediatric Infectious Disease Journal. 26: 836-40. PMID 17721381 DOI: 10.1097/Inf.0B013E318124A4Ae |
0.72 |
|
| 2007 |
Pyeon D, Newton MA, Lambert PF, den Boon JA, Sengupta S, Marsit CJ, Woodworth CD, Connor JP, Haugen TH, Smith EM, Kelsey KT, Turek LP, Ahlquist P. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Research. 67: 4605-19. PMID 17510386 DOI: 10.1158/0008-5472.Can-06-3619 |
0.79 |
|
| 2007 |
Smith EM, Ritchie JM, Pawlita M, Rubenstein LM, Haugen TH, Turek LP, Hamsikova E. Human papillomavirus seropositivity and risks of head and neck cancer. International Journal of Cancer. Journal International Du Cancer. 120: 825-32. PMID 17131312 DOI: 10.1002/Ijc.22330 |
0.742 |
|
| 2006 |
Berger KL, Barriga F, Lace MJ, Turek LP, Zamba GJ, Domann FE, Lee JH, Klingelhutz AJ. Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras. Virology. 356: 68-78. PMID 16945398 DOI: 10.1016/J.Virol.2006.07.039 |
0.647 |
|
| 2006 |
Parker TM, Smith EM, Ritchie JM, Haugen TH, Vonka V, Turek LP, Hamsikova E. Head and neck cancer associated with herpes simplex virus 1 and 2 and other risk factors. Oral Oncology. 42: 288-96. PMID 16324878 DOI: 10.1016/J.Oraloncology.2005.08.003 |
0.68 |
|
| 2005 |
Tachezy R, Klozar J, Saláková M, Smith E, Turek L, Betka J, Kodet R, Hamsíková E. HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Diseases. 11: 181-5. PMID 15888110 DOI: 10.1111/J.1601-0825.2005.01112.X |
0.773 |
|
| 2005 |
Wang D, Ritchie JM, Smith EM, Zhang Z, Turek LP, Haugen TH. Alcohol dehydrogenase 3 and risk of squamous cell carcinomas of the head and neck. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 626-32. PMID 15767341 DOI: 10.1158/1055-9965.Epi-04-0343 |
0.416 |
|
| 2005 |
Klozar J, Tachezy R, Saláková M, Smith E, Turek L, Betka J, Kodet R, Hamšíková E. PD.219 HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic Oral Oncology Supplement. 1: 133. DOI: 10.1016/S1744-7895(05)80337-2 |
0.597 |
|
| 2004 |
Smith EM, Ritchie JM, Yankowitz J, Wang D, Turek LP, Haugen TH. HPV prevalence and concordance in the cervix and oral cavity of pregnant women. Infectious Diseases in Obstetrics and Gynecology. 12: 45-56. PMID 15739817 DOI: 10.1080/10647440400009896 |
0.638 |
|
| 2004 |
Smith EM, Johnson SR, Ritchie JM, Feddersen D, Wang D, Turek LP, Haugen TH. Persistent HPV infection in postmenopausal age women. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 87: 131-7. PMID 15491557 DOI: 10.1016/J.Ijgo.2004.07.013 |
0.663 |
|
| 2004 |
Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, Turek LP. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. Journal of the National Cancer Institute. 96: 449-55. PMID 15026470 DOI: 10.1016/S1079-2104(03)00391-3 |
0.837 |
|
| 2004 |
Klussmann JP, Dinh S, Guntinas-Lichius O, Wittekindt C, Weissenborn S, Wieland U, Dienes HP, Hoffmann T, Smith E, Turek L, Speel EJ, Pfister HJ. [HPV-associated tonsillar cancer. An update]. Hno. 52: 208-18. PMID 15004685 DOI: 10.1007/S00106-004-1069-1 |
0.769 |
|
| 2004 |
Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. International Journal of Cancer. Journal International Du Cancer. 108: 766-72. PMID 14696105 DOI: 10.1002/Ijc.11633 |
0.844 |
|
| 2004 |
Smith EM, Ritchie JM, Yankowitz J, Swarnavel S, Wang D, Haugen TH, Turek LP. Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sexually Transmitted Diseases. 31: 57-62. PMID 14695959 DOI: 10.1097/01.Olq.0000105327.40288.Db |
0.662 |
|
| 2004 |
Smith EM, Haugen TH, Turek LP. RESPONSE: Re: Human Papillomavirus in Oral Exfoliated Cells and Risk of Head and Neck Cancer Jnci Journal of the National Cancer Institute. 96: 1182-1183. DOI: 10.1093/Jnci/Djh233 |
0.505 |
|
| 2004 |
Klussmann J, Dinh S, Wittekindt C, Turek L, Smith E, Speel E, Weißenborn S, Pfister H, Stennert E. HPV-DNA-Integration in Oropharynxkarzinomen Laryngo-Rhino-Otologie. 83. DOI: 10.1055/S-2004-823549 |
0.682 |
|
| 2003 |
Smith EM, Ritchie JM, Levy BT, Zhang W, Wang D, Haugen TH, Turek LP. Prevalence and persistence of human papillomavirus in postmenopausal age women. Cancer Detection and Prevention. 27: 472-80. PMID 14642556 DOI: 10.1016/S0361-090X(03)00104-1 |
0.747 |
|
| 2003 |
Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. International Journal of Cancer. Journal International Du Cancer. 104: 336-44. PMID 12569557 DOI: 10.1002/Ijc.10960 |
0.844 |
|
| 2002 |
Sprague DL, Phillips SL, Mitchell CJ, Berger KL, Lace M, Turek LP, Klingelhutz AJ. Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes. Virology. 301: 247-54. PMID 12359427 DOI: 10.1006/Viro.2002.1542 |
0.753 |
|
| 2002 |
Smith EM, Levy BT, Ritchie JM, Jia J, Wang D, Haugen TH, Turek LP. Is use of hormone replacement therapy associated with increased detection of human papillomavirus and potential risk of HPV-related genital cancers? European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 11: 295-305. PMID 12131663 DOI: 10.1097/00008469-200206000-00013 |
0.702 |
|
| 2001 |
Summersgill KF, Smith EM, Levy BT, Allen JM, Haugen TH, Turek LP. Human papillomavirus in the oral cavities of children and adolescents. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 91: 62-9. PMID 11174573 DOI: 10.1067/Moe.2001.108797 |
0.806 |
|
| 2000 |
Smith EM, Summersgill KF, Allen J, Hoffman HT, McCulloch T, Turek LP, Haugen TH. Human papillomavirus and risk of laryngeal cancer. The Annals of Otology, Rhinology, and Laryngology. 109: 1069-76. PMID 11090000 DOI: 10.1177/000348940010901114 |
0.83 |
|
| 2000 |
Kutza J, Smith E, Levy B, Jian J, Haugen T, Turek L. Use of hormone replacement therapy (Hrt) And detection of human papillomavirus (Hpv) Dna in postmenopausal women. Annals of Epidemiology. 10: 465-466. PMID 11018386 DOI: 10.1016/S1047-2797(00)00090-9 |
0.696 |
|
| 2000 |
Summersgill KF, Smith EM, Kirchner HL, Haugen TH, Turek LP. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 90: 334-9. PMID 10982955 DOI: 10.1067/Moe.2000.107359 |
0.824 |
|
| 1998 |
Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. The Laryngoscope. 108: 1098-103. PMID 9665264 DOI: 10.1097/00005537-199807000-00027 |
0.753 |
|
| 1998 |
Sethi S, Müller M, Schneider A, Blettner M, Smith E, Turek L, Wahrendorf J, Gissmann L, Chang-Claude J. Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women. American Journal of Obstetrics and Gynecology. 178: 360-4. PMID 9500500 DOI: 10.1016/S0002-9378(98)80026-4 |
0.39 |
|
| 1997 |
Smith EM, Johnson SR, Figuerres EJ, Mendoza M, Fedderson D, Haugen TH, Turek LP. The frequency of human papillomavirus detection in postmenopausal women on hormone replacement therapy. Gynecologic Oncology. 65: 441-6. PMID 9190973 DOI: 10.1006/Gyno.1997.4703 |
0.761 |
|
| 1996 |
Turek LP, Smith EM. The genetic program of genital human papillomaviruses in infection and cancer. Obstetrics and Gynecology Clinics of North America. 23: 735-58. PMID 8989774 DOI: 10.1016/S0889-8545(05)70275-8 |
0.647 |
|
| 1996 |
Summersgill K, Smith E, Hoffman H, Ricks J, Haugen T, Turek L. Cancer risk factors and HPV frequency in control and oral squamous cell carcinoma patients Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 82: 211. DOI: 10.1016/S1079-2104(96)80253-8 |
0.803 |
|
| 1994 |
Turek LP. The structure, function, and regulation of papillomaviral genes in infection and cervical cancer. Advances in Virus Research. 44: 305-56. PMID 7817876 DOI: 10.1016/S0065-3527(08)60332-2 |
0.657 |
|
| 1993 |
Smith EM, Pignatari SS, Gray SD, Haugen TH, Turek LP. Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. Archives of Otolaryngology--Head & Neck Surgery. 119: 554-7. PMID 8387317 DOI: 10.1001/Archotol.1993.01880170080017 |
0.739 |
|
| 1992 |
Pignatari S, Smith EM, Gray SD, Shive C, Turek LP. Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. The Annals of Otology, Rhinology, and Laryngology. 101: 408-12. PMID 1315130 DOI: 10.1177/000348949210100506 |
0.684 |
|
| 1992 |
Ishiji T, Lace M, Parkkinen S, Anderson R, Haugen T, Cripe T, Xiao J, Davidson I, Chambon P, Turek L. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. The Embo Journal. 11: 2271-2281. DOI: 10.1002/J.1460-2075.1992.Tb05286.X |
0.711 |
|
| 1991 |
Smith EM, Johnson SR, Cripe TP, Pignatari S, Turek L. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. The Annals of Otology, Rhinology, and Laryngology. 100: 479-83. PMID 1647745 DOI: 10.1177/000348949110000610 |
0.755 |
|
| 1989 |
Kleinheinz A, von Knebel Doeberitz M, Cripe TP, Turek LP, Gissmann L. Human papillomavirus early gene products and maintenance of the transformed state of cervical cancer cells in vitro. Current Topics in Microbiology and Immunology. 144: 175-9. PMID 2551582 DOI: 10.1007/978-3-642-74578-2_21 |
0.666 |
|
| 1989 |
Levenson RM, Brinckmann UG, O'Banion MK, Androphy EJ, Schiller JT, Tabatabai F, Turek LP, Neary K, Chin MT, Broker TR. Papillomavirus-associated inductions of cellular proteins in mouse C127 cells: correlation with the presence of open reading frame E2. Virology. 172: 170-9. PMID 2549708 DOI: 10.1016/0042-6822(89)90118-9 |
0.3 |
|
| 1987 |
Cripe TP, Haugen TH, Turk JP, Tabatabai F, Schmid PG, Dürst M, Gissmann L, Roman A, Turek LP. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. The Embo Journal. 6: 3745-3753. DOI: 10.1002/j.1460-2075.1987.tb02709.x |
0.329 |
|
| Show low-probability matches. |